Fig. 1From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasmsExpression of miRNA in serum from type 1 g-NEN patients and control participants. Patients type 1 g-NEN patients; CON control participantsBack to article page